Bioremediation and monitored natural attenuation are among the most cost-effective approaches to manage soil and groundwater contamination by hazardous organic pollutants. However, these remediation alternatives are not universally applicable and may be marginally effective for recalcitrant pollutants if the necessary microbial catabolic capacity is not present or expressed. Thus, regulatory and public approval of bioremediation and natural attenuation requires documentation of the efficacy of microbial degradation of the target pollutants. Performance assessment generally consists of three components: documented contaminant mass loss, geochemical fingerprints associated with biodegradation, and microcosm studies that show direct evidence of biodegradation. More recently, new molecular and isotope fractionation techniques have emerged to complement existing technologies for the forensic analysis and the demonstration of bioremediation and natural attenuation. This critical review examines the current state-of-art in performance assessment methods and discusses future research directions.
No takes yet. Share an insight, caveat, or question.
Illman et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: